Corcept (CORT) Down 4% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Corcept Therapeutics Incorporated (CORT)
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corcept.com/investors
Company Research
Source: Yahoo! Finance
Will the recent negative trend continue leading up to its next earnings release, or is Corcept due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Corcept Q2 Earnings & Revenues Surpass Estimates Corcept reported second-quarter 2024 earnings of 32 cents per share, which beat the Zacks Consensus Estimate of 23 cents. The company had reported earnings of 25 cents per share in the year-ago quarter. Revenues increased 39% year over year to $163.8 million. The figure also beat the Zacks Consensus Estimate of $154 million. The top line solely comprises product sales of Cushing's syndrome drug, Korlym. Quarter in Detail Revenues from Korlym beat our model estimate of $152.4 million. Research and development expenses surged 35.5% year over year to $58.7 million. Selling, general and administrative expenses increased around
Show less
Read more
Impact Snapshot
Event Time:
CORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CORT alerts
High impacting Corcept Therapeutics Incorporated news events
Weekly update
A roundup of the hottest topics
CORT
News
- Does Corcept Therapeutics (CORT) Have a Long Runway for Growth? [Yahoo! Finance]Yahoo! Finance
- Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Piper Sandler from $38.00 to $67.00. They now have an "overweight" rating on the stock.MarketBeat
- Corcept Therapeutics - Three Dynamic Catalysts To Reaccelerate Growth [Seeking Alpha]Seeking Alpha
- Here's Why Corcept Therapeutics (NASDAQ:CORT) Has Caught The Eye Of Investors [Yahoo! Finance]Yahoo! Finance
- Corcept Shares Rise More Than 45% in Six Months: Here's Why [Yahoo! Finance]Yahoo! Finance
CORT
Earnings
- 7/29/24 - Beat
CORT
Sec Filings
- 9/19/24 - Form 4
- 9/5/24 - Form 4
- 9/5/24 - Form 4
- CORT's page on the SEC website